Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Purgato

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Epidemiology and Psychiatric Sciences|March 20, 2014
Does psychostimulant treatment in children with ADHD increase later risk of substance use disorder?M Purgato, S Cortese
Epidemiology and Psychiatric Sciences|August 1, 2012
What is the WHO essential medicines list?M Purgato, C Barbui
Epidemiology and Psychiatric Sciences|October 24, 2012
Dichotomizing rating scale scores in psychiatry: a bad idea?M Purgato, C Barbui
Epidemiology and Psychiatric Sciences|June 8, 2012
Heterogeneity: the issue of apples, oranges and fruit pieM Purgato, C E Adams
Epidemiology and Psychiatric Sciences|September 20, 2016
An ecological model for refugee mental health: implications for researchM Purgato, W A Tol, J K Bass
Psychological Medicine|July 29, 2014
Pragmatic design in randomized controlled trialsM Purgato, C Barbui, S Stroup, et al.
Epidemiology and Psychiatric Sciences|September 25, 2015
Mental health and psychosocial support in humanitarian settings: a public mental health perspectiveW A Tol, M Purgato, J K Bass, et al.
International Review of Psychiatry (Abingdon, England)|April 27, 2023
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions?M Nosè, C Gastaldon, C Acarturk, et al.
Acta Psychiatrica Scandinavica|December 16, 2014
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetineM Purgato, C Gastaldon, D Papola, et al.
Epidemiology and Psychiatric Sciences|February 2, 2013
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological surveyC Barbui, V Conti, M Purgato, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Epidemiology and Psychiatric Sciences|March 20, 2014
Does psychostimulant treatment in children with ADHD increase later risk of substance use disorder?M Purgato, S Cortese
Epidemiology and Psychiatric Sciences|August 1, 2012
What is the WHO essential medicines list?M Purgato, C Barbui
Epidemiology and Psychiatric Sciences|October 24, 2012
Dichotomizing rating scale scores in psychiatry: a bad idea?M Purgato, C Barbui
Epidemiology and Psychiatric Sciences|June 8, 2012
Heterogeneity: the issue of apples, oranges and fruit pieM Purgato, C E Adams
Epidemiology and Psychiatric Sciences|September 20, 2016
An ecological model for refugee mental health: implications for researchM Purgato, W A Tol, J K Bass
Psychological Medicine|July 29, 2014
Pragmatic design in randomized controlled trialsM Purgato, C Barbui, S Stroup, et al.
Epidemiology and Psychiatric Sciences|September 25, 2015
Mental health and psychosocial support in humanitarian settings: a public mental health perspectiveW A Tol, M Purgato, J K Bass, et al.
International Review of Psychiatry (Abingdon, England)|April 27, 2023
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions?M Nosè, C Gastaldon, C Acarturk, et al.
Acta Psychiatrica Scandinavica|December 16, 2014
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetineM Purgato, C Gastaldon, D Papola, et al.
Epidemiology and Psychiatric Sciences|February 2, 2013
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological surveyC Barbui, V Conti, M Purgato, et al.
Pageof 2